OBJECTIVE: Treatment recommendation and guidelines for patients with heart failure (HF) can be complex, and past work has shown that patients with HF demonstrate low rates of adherence to recommended health behaviors. Although previous work has identified several medical, demographic, and psychosocial predictors of the capacity to adhere to treatment recommendations of persons with HF, little is known about the contribution of cognitive impairment to reported treatment adherence in this population. METHODS: A total of 149 persons with HF (mean [standard deviation] = 68.08 [10.74] years) completed a brief fitness assessment and neuropsychological testing. Treatment adherence was assessed using the Heart Failure Compliance Questionnaire, a brief measure that asks participants to report their adherence to a variety of recommended health behaviors (i.e., medication management, diet, and exercise, among others). RESULTS: The percentage of participants who reported poor overall adherence was 16.1%, with particularly high rates of nonadherence to dietary and exercise recommendations. Hierarchical regression analyses adjusting for possible confounds revealed that reduced performance on attention (β = .26, p = .01), executive function (β = .18, p = .04), and language (β = .22, p = .01) was associated with poorer overall adherence. Follow-up analyses showed that these cognitive domains were associated with behaviors such as keeping doctor appointments, medication management, and dietary recommendations (p < .05 for all). CONCLUSIONS: The current findings demonstrate that cognitive function is an independent contributor to adherence in older adults with HF. Prospective studies that objectively measure treatment adherence are needed to clarify these findings and identify possible strategies to improve outcomes in this population. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00871897.
OBJECTIVE: Treatment recommendation and guidelines for patients with heart failure (HF) can be complex, and past work has shown that patients with HF demonstrate low rates of adherence to recommended health behaviors. Although previous work has identified several medical, demographic, and psychosocial predictors of the capacity to adhere to treatment recommendations of persons with HF, little is known about the contribution of cognitive impairment to reported treatment adherence in this population. METHODS: A total of 149 persons with HF (mean [standard deviation] = 68.08 [10.74] years) completed a brief fitness assessment and neuropsychological testing. Treatment adherence was assessed using the Heart Failure Compliance Questionnaire, a brief measure that asks participants to report their adherence to a variety of recommended health behaviors (i.e., medication management, diet, and exercise, among others). RESULTS: The percentage of participants who reported poor overall adherence was 16.1%, with particularly high rates of nonadherence to dietary and exercise recommendations. Hierarchical regression analyses adjusting for possible confounds revealed that reduced performance on attention (β = .26, p = .01), executive function (β = .18, p = .04), and language (β = .22, p = .01) was associated with poorer overall adherence. Follow-up analyses showed that these cognitive domains were associated with behaviors such as keeping doctor appointments, medication management, and dietary recommendations (p < .05 for all). CONCLUSIONS: The current findings demonstrate that cognitive function is an independent contributor to adherence in older adults with HF. Prospective studies that objectively measure treatment adherence are needed to clarify these findings and identify possible strategies to improve outcomes in this population. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00871897.
Authors: Edward P Havranek; Frederick A Masoudi; Kelly A Westfall; Pam Wolfe; Diana L Ordin; Harlan M Krumholz Journal: Am Heart J Date: 2002-03 Impact factor: 4.749
Authors: J R C Almeida; T C T F Alves; M Wajngarten; J Rays; C C Castro; Q Cordeiro; R M S Telles; R J Fraguas; G F Busatto Journal: Braz J Med Biol Res Date: 2005-03-08 Impact factor: 2.590
Authors: Raymond L C Vogels; Wiesje M van der Flier; Barbera van Harten; Alida A Gouw; Philip Scheltens; Jutta M Schroeder-Tanka; Henry C Weinstein Journal: Eur J Heart Fail Date: 2007-08-23 Impact factor: 15.534
Authors: Nicole Holzapfel; Bernd Löwe; Beate Wild; Dieter Schellberg; Christian Zugck; Andrew Remppis; Hugo A Katus; Markus Haass; Bernhard Rauch; Jana Jünger; Wolfgang Herzog; Thomas Müller-Tasch Journal: Heart Lung Date: 2009-01-21 Impact factor: 2.210
Authors: S Mayo; H A Messner; S B Rourke; D Howell; J C Victor; J Kuruvilla; J H Lipton; V Gupta; D D Kim; C Piescic; D Breen; A Lambie; D Loach; F V Michelis; N Alam; J Uhm; L McGillis; K Metcalfe Journal: Bone Marrow Transplant Date: 2016-02-29 Impact factor: 5.483
Authors: Mary A Dolansky; Misty A W Hawkins; Julie T Schaefer; Abdus Sattar; John Gunstad; Joseph D Redle; Richard Josephson; Shirley M Moore; Joel W Hughes Journal: Circ Heart Fail Date: 2016-12 Impact factor: 8.790
Authors: Krysten K Fulcher; Michael L Alosco; Lindsay Miller; Mary Beth Spitznagel; Ronald Cohen; Naftali Raz; Lawrence Sweet; Lisa H Colbert; Richard Josephson; Joel Hughes; Jim Rosneck; John Gunstad Journal: Health Psychol Date: 2014-01-27 Impact factor: 4.267
Authors: Michael L Alosco; Adam M Brickman; Mary Beth Spitznagel; Erica Y Griffith; Atul Narkhede; Naftali Raz; Ronald Cohen; Lawrence H Sweet; Lisa H Colbert; Richard Josephson; Joel Hughes; Jim Rosneck; John Gunstad Journal: J Neurol Sci Date: 2013-03-23 Impact factor: 3.181